Fostamatinib

Last Updated: 02/24/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 356 publications

Management of autoimmune hemolytic anemia.

Management of autoimmune hemolytic anemia.

Journal: Hematology. American Society of Hematology. Education Program

Published: December 05, 2025

Construction of Metastasis Prediction Models and Screening of Anti-Metastatic Drugs Based on Pan-Cancer Single-Cell EMT Features.

Construction of Metastasis Prediction Models and Screening of Anti-Metastatic Drugs Based on Pan-Cancer Single-Cell EMT Features.

Journal: International journal of molecular sciences

Published: October 30, 2025

Real-World Effectiveness and Safety of Fostamatinib in Difficult-to-Treat Immune Thrombocytopenia Patients. A Prospective, Multicenter Registry in France.

Real-World Effectiveness and Safety of Fostamatinib in Difficult-to-Treat Immune Thrombocytopenia Patients. A Prospective, Multicenter Registry in France.

Journal: American journal of hematology

Published: September 18, 2025

Network Controllability Reveals Key Mitigation Points for Tumor-Promoting Signaling in Tumor-Educated Platelets.

Network Controllability Reveals Key Mitigation Points for Tumor-Promoting Signaling in Tumor-Educated Platelets.

Journal: International journal of molecular sciences

Published: September 16, 2025

Successful Salvage Treatment With Fostamatinib for an Adolescent Patient With Refractory Chronic Immune Thrombocytopenia.

Successful Salvage Treatment With Fostamatinib for an Adolescent Patient With Refractory Chronic Immune Thrombocytopenia.

Journal: Cureus

Published: September 03, 2025

Future directions in the management of warm autoimmune hemolytic anemia

Future directions in the management of warm autoimmune hemolytic anemia

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: September 03, 2025

Single-cell transcriptome-wide Mendelian randomization and colocalization reveal cell-specific mechanisms in systemic lupus erythematosus.

Single-cell transcriptome-wide Mendelian randomization and colocalization reveal cell-specific mechanisms in systemic lupus erythematosus.

Journal: Rheumatology (Oxford, England)

Published: August 18, 2025

Thrombopoietin agonists in monotherapy or associated with fostamatinib in severe or refractory thrombocytopenias to immunosuppressants in patients with systemic lupus erythematosus.

Thrombopoietin agonists in monotherapy or associated with fostamatinib in severe or refractory thrombocytopenias to immunosuppressants in patients with systemic lupus erythematosus.

Journal: Medicina clinica

Published: August 12, 2025

Fostamatinib (R788), a spleen tyrosine kinase inhibitor, sensitizes pancreatic cancer cells to oncolytic vesicular stomatitis virus.

Fostamatinib (R788), a spleen tyrosine kinase inhibitor, sensitizes pancreatic cancer cells to oncolytic vesicular stomatitis virus.

Journal: Molecular therapy. Oncology

Published: July 11, 2025

Novel second-line treatments for immune thrombocytopenia

Novel second-line treatments for immune thrombocytopenia

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: July 06, 2025

SIK2 Drives Pulmonary Fibrosis by Enhancing Fibroblast Glycolysis and Activation.

SIK2 Drives Pulmonary Fibrosis by Enhancing Fibroblast Glycolysis and Activation.

Journal: Biomedicines

Published: June 24, 2025

Combining an immunomodulatory drug with a TPO-RA to treat multirefractory ITP patients: The Spanish ITP Group experience.

Combining an immunomodulatory drug with a TPO-RA to treat multirefractory ITP patients: The Spanish ITP Group experience.

Journal: British journal of haematology

Published: June 18, 2025

Showing 1-12 of 356

Last Updated: 02/24/2026